All In MedTech

Device Trial Radar · NCT02408471

Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis

Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis

Last checked: Nov 20, 2026Latest source record: Oct 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

97

Actual

Start

Jun 2002

Primary completion

Jan 2015

Study completion Jan 2015

Sponsor

Lead sponsor
Smith & Nephew, Inc.Public (SNN)
Sponsor type
Industry
First posted
Apr 3, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a non-randomized, consecutive enrollment, one-year post-approval study of patients who are treated with the Ascension® MCP.

Conditions

  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Osteoarthritis
  • Post-traumatic Arthritis

Interventions

  • Ascension® MCP Finger ImplantDevice

    Patients who meet inclusion/ exclusion criteria are treated with the Ascension® MCP.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With RevisionsTime frame: 12 months

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Southwest Shoulder Elbow and Hand Center, P.C.

    Tucson, Arizona

  • Bloomington Bone and Joint Clinic

    Bloomington, Indiana

  • Reconstructive Hand Surgeons of Indiana

    Carmel, Indiana

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.